3,489 Shares in Chemed Co. (NYSE:CHE) Acquired by Sanctuary Advisors LLC

Sanctuary Advisors LLC purchased a new stake in Chemed Co. (NYSE:CHE) during the second quarter, according to the company in its most recent filing with the SEC. The firm purchased 3,489 shares of the company’s stock, valued at approximately $1,955,000.

Other hedge funds also recently made changes to their positions in the company. Rise Advisors LLC purchased a new position in shares of Chemed in the 1st quarter worth $26,000. GAMMA Investing LLC grew its stake in Chemed by 34.4% during the second quarter. GAMMA Investing LLC now owns 86 shares of the company’s stock worth $47,000 after buying an additional 22 shares during the period. Mather Group LLC. acquired a new stake in shares of Chemed in the first quarter worth $67,000. EntryPoint Capital LLC raised its stake in shares of Chemed by 14.0% in the 1st quarter. EntryPoint Capital LLC now owns 147 shares of the company’s stock valued at $94,000 after acquiring an additional 18 shares during the period. Finally, Quarry LP lifted its holdings in shares of Chemed by 721.7% during the 2nd quarter. Quarry LP now owns 189 shares of the company’s stock valued at $103,000 after acquiring an additional 166 shares in the last quarter. Institutional investors and hedge funds own 95.85% of the company’s stock.

Insider Buying and Selling

In related news, EVP Nicholas Michael Westfall sold 2,000 shares of the stock in a transaction dated Tuesday, July 30th. The stock was sold at an average price of $561.58, for a total value of $1,123,160.00. Following the completion of the transaction, the executive vice president now owns 5,990 shares of the company’s stock, valued at approximately $3,363,864.20. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. In other news, Director Andrea R. Lindell sold 831 shares of the business’s stock in a transaction dated Friday, August 16th. The shares were sold at an average price of $571.51, for a total value of $474,924.81. Following the completion of the sale, the director now owns 5,725 shares of the company’s stock, valued at approximately $3,271,894.75. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Nicholas Michael Westfall sold 2,000 shares of the company’s stock in a transaction dated Tuesday, July 30th. The shares were sold at an average price of $561.58, for a total transaction of $1,123,160.00. Following the completion of the sale, the executive vice president now owns 5,990 shares in the company, valued at approximately $3,363,864.20. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 9,144 shares of company stock valued at $5,264,839 in the last quarter. Company insiders own 3.32% of the company’s stock.

Chemed Trading Up 1.7 %

Shares of Chemed stock opened at $587.53 on Wednesday. The company has a fifty day moving average price of $580.10 and a 200 day moving average price of $572.57. Chemed Co. has a twelve month low of $497.36 and a twelve month high of $654.62. The stock has a market cap of $8.89 billion, a price-to-earnings ratio of 31.62, a price-to-earnings-growth ratio of 2.40 and a beta of 0.44.

Chemed (NYSE:CHE) last released its quarterly earnings results on Wednesday, July 24th. The company reported $5.47 EPS for the quarter, missing the consensus estimate of $5.59 by ($0.12). Chemed had a return on equity of 29.21% and a net margin of 12.88%. The company had revenue of $595.88 million for the quarter, compared to analyst estimates of $599.20 million. During the same period last year, the firm posted $4.71 earnings per share. The business’s revenue was up 7.6% on a year-over-year basis. Analysts forecast that Chemed Co. will post 21.77 earnings per share for the current year.

Chemed Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, August 30th. Investors of record on Monday, August 12th were issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 0.34%. This is a positive change from Chemed’s previous quarterly dividend of $0.40. The ex-dividend date of this dividend was Monday, August 12th. Chemed’s dividend payout ratio (DPR) is presently 10.76%.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.